Vir Biotechnology, Inc. (VIR)
10.71
+0.80
(+8.07%)
USD |
NASDAQ |
Aug 25, 16:00
10.75
+0.04
(+0.37%)
Pre-Market: 09:15
Vir Biotechnology Total Assets (Quarterly) : 1.215B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.215B |
| March 31, 2026 | 1.026B |
| December 31, 2025 | 1.025B |
| September 30, 2025 | 1.019B |
| June 30, 2025 | 1.193B |
| March 31, 2025 | 1.308B |
| December 31, 2024 | 1.424B |
| September 30, 2024 | 1.498B |
| June 30, 2024 | 1.670B |
| March 31, 2024 | 1.794B |
| December 31, 2023 | 1.960B |
| September 30, 2023 | 2.045B |
| June 30, 2023 | 2.244B |
| March 31, 2023 | 2.666B |
| December 31, 2022 | 3.052B |
| September 30, 2022 | 2.696B |
| Date | Value |
|---|---|
| June 30, 2022 | 2.619B |
| March 31, 2022 | 2.887B |
| December 31, 2021 | 2.051B |
| September 30, 2021 | 1.210B |
| June 30, 2021 | 1.058B |
| March 31, 2021 | 1.136B |
| December 31, 2020 | 918.76M |
| September 30, 2020 | 943.26M |
| June 30, 2020 | 672.24M |
| March 31, 2020 | 477.11M |
| December 31, 2019 | 512.07M |
| September 30, 2019 | 422.64M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 191.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Caribou Biosciences, Inc. | 142.77M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 232.31M |
| Shareholders Equity (Quarterly) | 982.49M |
| Debt to Equity Ratio | 0.0949 |
| Current Ratio | 6.042 |
| Net Debt Paydown Yield | 0.03% |